摘要:
sci-hub.se 参考文章(32)
Robert Gelber, John H. Peters, G. Ross Gordon, Anthony J. Glazko, Louis Levy, The polymorphic acetylation of dapsone in man. Clinical Pharmacology & Therapeutics. ,vol. 12, pp. 225- 238 ,(1971) , 10.1002/CPT1971122PART1225
G. A. ELLARD, PATRICIA T. GAMMON, R. J. W. REES, The minimal inhibitory concentrations of sulphadimethozine and sulphadoxine against Mycobacterium leprae. Leprosy Review. ,vol. 41, pp. 223- ,(1970) , 10.5935/0305-7518.19700031
J. C. HATHAWAY, Chemotherapeutic trial of combined capreomycin and diasone. Leprosy Review. ,vol. 41, pp. 181- ,(1970) , 10.5935/0305-7518.19700027
D. L. LEIKER, H. KAMP, First results of treatment of leprosy with Rifadin. Leprosy Review. ,vol. 41, pp. 25- 30 ,(1970) , 10.5935/0305-7518.19700005
T.F. Davey, Some recent chemotherapeutic work in leprosy: with a discussion of some of the problems involved in clinical trials. Transactions of The Royal Society of Tropical Medicine and Hygiene. ,vol. 54, pp. 199- 206 ,(1960) , 10.1016/0035-9203(60)90062-6
David Chernof, Dapsone-Induced Hemolysis in G6PD Deficiency JAMA: The Journal of the American Medical Association. ,vol. 201, pp. 554- 556 ,(1967) , 10.1001/JAMA.1967.03130070074028
M. A. Blajchman, R. C. Lowry, J. E. Pettit, P. Stradling, Rifampicin-induced Immune Thrombocytopenia BMJ. ,vol. 3, pp. 24- 26 ,(1970) , 10.1136/BMJ.3.5713.24
Charles C. Shepard, THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICE Journal of Experimental Medicine. ,vol. 112, pp. 445- 454 ,(1960) , 10.1084/JEM.112.3.445
B.M. Dajani, M.S. Canady, J.S. Thompson, J.E. Kasik, Rifampicin: an immunosuppressant? The Lancet. ,vol. 300, pp. 1094- ,(1972) , 10.1016/S0140-6736(72)92390-2
R. J. W. REES, Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature. ,vol. 211, pp. 657- 658 ,(1966) , 10.1038/211657A0